Delivery Order SPE2DE24D0013-SPE2D625F1MDM
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $2,723.58 by the Defense Department's Medical Supply Chain on August 5, 2025, with an ultimate completion date of August 12, 2025. The contract, which carries no set-aside designation, represents a delivery order under one of Cepheid's existing Indefinite Delivery Vehicles with the Department of Veterans Affairs. Cepheid specializes in advanced...
- Cepheid Inc., a manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,024 on August 13, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, contract number 4569079036, is scheduled for completion by August 20, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no set-aside designation, allowing the company to compete on an unrestricted basis....
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $1,840 on August 11, 2025, by the Defense Department's Medical Supply Chain agency. This firm fixed-price contract, designated as XPRSTREPA-10, is set to conclude by August 18, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract represents a discrete delivery order under Cepheid's existing federal contracting relationships, through which the...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $10.2K delivery order (Contract No. 4569067497) by the Defense Logistics Agency's Medical Supply Chain division on August 12, 2025, with a completion date of August 19, 2025. The contract utilizes firm fixed-price pricing with no set-aside designation and represents a delivery order against one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts. Performance will take place...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,539.30 by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order does not utilize a set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies to federal healthcare systems. The contract will be performed in...
- Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a firm fixed-price delivery order valued at $14,960 by the Defense Department's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 21, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions, specifically molecular reagents and assays for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. This award carries...
- Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, was awarded a delivery order valued at $2,471.70 by the Medical Supply Chain division of the Defense Department on August 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is scheduled for ultimate completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract award references XPRSARS-COV2-10, indicating the delivery order...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, has been awarded a delivery order valued at $1,605.00 under contract GXMRSA-NXG-10, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is funded by the Defense Medical Supply Chain, a defense-focused federal agency. The award represents Cepheid's continued provision of molecular diagnostic technologies and services to the...
- Cepheid has been awarded a delivery order valued at $7,276 under contract number 4568920470 for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. This firm fixed-price delivery order, issued by the Medical Supply Chain division of the Department of Defense, will be performed in Sunnyvale, California, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation and represents a continuation of...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1MDMDelivery Order
Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale, California. This delivery order likely draws from one of Cepheid's two significant Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, including a $32.8 million single-award IDV with VA's Veterans Integrated Service Network 6 through September 30, 2030, or the $2.5 million IDV with Veterans Integrated Service Network 21. These vehicles enable Cepheid to supply molecular diagnostic testing system reagents, assays, and PCR testing capabilities for detecting infectious diseases including COVID-19, influenza, RSV, and other clinical conditions across the federal healthcare enterprise. The company's established track record with the Defense Logistics Agency and Veterans Affairs positions it as a key provider of advanced diagnostic technologies to support military medical readiness and veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/20/25 |